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Photodynamic therapy (PDT) has recently been approved by
various regulatory agencies for the treatment of certain cancers
(Hasan and Parrish, 1996; Dougherty et al, 1998). Investigations
of cellular molecular responses to PDT reveal release of prosta-
glandin E2 (PGE2) (Henderson and Donovan, 1989), histamine
release from mast cells (Glover et al, 1989), increased transcrip-
tion and translation of some oxidative stress genes (Gomer et al,
1989) including haem oxygenase (Gomer et al, 1991), and the heat
shock protein, Hsp70 (Gomer et al, 1988). More long-term effects,
such as resistance to photosensitization (Singh et al, 1991;
DiProspero et al, 1997) and mutation (Evans et al, 1989) could be
the result of PDT-induced DNA single-strand breaks, sister chro-
matid exchanges or other chromosomal aberrations (Gomer et al,
1983).
PDT often leaves a significant number of surviving tumour cells
which have been exposed to both light and photosensitizer but not
enough of either to be destroyed. Our interest was an investigation
of such cells, because of their potential impact on long-term effects
of PDT. For example, a reduction in metastases has been reported in
vivo after PDT compared to after surgery (Gomer et al, 1987), but
no studies directly investigating the molecular basis of this observa-
tion have been reported. However, recent studies point to the inter-
twined nature of angiogenesis, tumorigenesis and extracellular
matrix (ECM) metabolism (Ingber and Folkman, 1988; Brem et al,
1993). The complex nature of the mechanisms in cell and tissue
damage in response to PDT could profoundly influence the
metastatic process. Along these lines it was shown that PDT causes
cellular membrane damage (Malik and Djaldetti, 1980; Evenson et
al, 1984; Moan and Vistnes, 1986), and tumour cells treated with
Photofrin® (PF®)-based PDT release compounds such as
prostanoids including prostaglandin E2 (PGE2), prostacyclin, throm-
boxane (TX) and von Willebrand factor (vWf) (Henderson and
Donovan, 1989; Fingar et al, 1990; Foster et al, 1991). PGE2 has
been shown to directly influence the in vivo dissemination and in
vitro migration of Lewis lung carcinoma cells (Young et al, 1987),
and differences exist in the amount of synthesis of PGE2 and prosta-
cyclin by normal, tumour and metastatic cells (Young et al, 1987). In
addition, inhibition of the cyclooxygenase pathway renders tumour
cells non-invasive and non-metastatic (Reich et al, 1989). TX and
vWf are both involved in platelet aggregation and adhesion, which
have been shown to play a role in metastasis in vivo (Karpatkin et al,
1988). Most recently, Foultier et al (1994) found that PDT using
hematoporphyrin derivative (HPD-PDT) decreased the adhesive-
ness of colonic cancer cells to endothelial cell monolayers.
The present study focuses on one cellular response to PDT
relevant to the above discussion, and that is the effect on cellular
adhesion to ECM proteins. A group of cell surface proteins that
contribute to cell adhesion, differentiation and malignant transfor-
mation processes are the integrins. These are heterodimeric cell
surface receptors composed of a and b subunits. Generally, both
subunits have long extracellular domains and small cytoplasmic
domains. Integrins serve to link the external and internal cellular
environments by functioning in transmembrane signalling
(Schwartz, 1992). Integrin up- and down-regulation has been
associated with malignant transformation (Plantefaber and Hynes,
1989; Schreiner et al, 1989; Albeda et al, 1990; Dedhar and
Saulnier, 1990; Giancotti and Ruoslahti 1990; Schreiner et al,
1991) and metastasis (Plantefaber and Hynes, 1989; Roosien et al,
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1989; Chan et al, 1991). vWF can bind directly to malignant
haematopoietic cell lines at an integrin membrane receptor site
(Floyd et al, 1992), facilitating interactions of tumour cells alone or
tumour cell–platelet heterotypic aggregates (Jamieson, 1987) with
the vascular endothelium. Adhesion to the ECM or endothelium,
and subsequent migration through vessel walls, is also mediated by
integrins. A role for integrin-mediated signalling in ovarian cancer
has also been suggested (Buczek-Thomas et al, 1998).
In this study we report the effects of benzoporphyrin derivative
monoacid (BPD-MA)-mediated PDT on integrin function and cell
adhesion of ovarian cancer cells in vitro and in vivo. BPD-MA
(Richter et al, 1987, 1990) was chosen because it is a photo-
sensitizer in phase I–III clinical trials (Levy, 1994) and, unlike
Photofrin, prolonged cutaneous phototoxicity with BPD-MA is
not significant, and use of 690 nm light allows better penetration
of tissue (Wilson, 1989).
MATERIALS AND METHODS
Cells and cell culture
The human ovarian cancer cell line NIH: OVCAR 3 was used in
all experiments and was obtained from Dr Thomas Hamilton (Fox
Chase Cancer Center, Philadelphia, PA, USA). The cells were
maintained in RPMI-1640 supplemented with 10% heat-inacti-
vated fetal calf serum (FCS; GIBCO Laboratories, Grand Island,
NY) at 37°C in a 5% carbon dioxide atmosphere.
Photosensitizer
BPD-MA was a generous gift of QLT PhotoTherapeutics Inc.
(Vancouver, Canada). The compound was stored at –70°C in
dimethyl sulphoxide (DMSO). It was diluted in media, and the
concentration determined spectrophotometrically (e690 = 32 350)
before each use.
BPD-MA photosensitization
In-vitro, the cells were plated in 35-mm tissue culture dishes at
least 24 h before irradiation. Densities were chosen so that the
plates were approximately 50% confluent at the time of photosen-
sitization. The cells were labelled with 8.5 mCi ml–1 [35S]methio-
nine for approximately 18 h before photosensitization. Adequate
incorporation of radioactivity was achieved in the growth media
for this incubation period. Cells were incubated with 0.092 mmol
l–1 (0.066 mg ml–1) BPD-MA for 3 h before irradiations. The cells
were then washed with and irradiated in phosphate-buffered saline
(PBS). Irradiations were 0.5 J cm–2 (at intensities of of 0.02–
0.03 W cm–2) 690 nm light provided by an argon ion pumped dye
laser (Coherent, Palo Alto, CA, USA). After irradiation, the cells
were returned to media and incubated at 37°C before they were
analysed for adhesion or b1 integrin expression.
In-vivo, a nude mouse model was used (Goff et al, 1996).
OVCAR 3 cells were injected intraperitoneally (i.p.) into nude
mice and tumours were allowed to develop for 10–14 days. At this
point, the tumour cells are largely ascitic. The animals were then
injected i.p. with 2 mg kg–1 BPD-MA 3 h before irradiations.
Irradiations were done with two diffusing tip fibres and 2 ml of
0.2% intralipid as the diffusing medium as described (Molpus et
al, 1996). Fluence was calculated at the skin surface at each fibre
as 20 J cm–2 using the procedure described in Lilge et al (1994).
The ascitic fluid and cells were tapped 1 h after irradiation.
Tumour cells were pelleted by centrifugation, treated with 0.83%
NH4Cl for 5 min to lyse the red blood cell component, counted and
placed in RPMI with 10% FCS and 12.5 mCi per dish [35S]methio-
nine at a density of 7 ´ 105 per 35-mm dish. Approximately 15 h
later the cells were assayed for adhesion as described below.
Adhesion assays
For adhesion assay, 96-well Falcon ‘Probind’ Immunoassay plates
(Becton Dickinson, Lincoln Park, NJ, USA) were coated with
ECM proteins 24 h in advance of their use. Each well was coated
with 100 ml of one of the following solutions: 2 mg ml–1 human
collagen IV, human fibronectin, or human vitronectin, or
10 mg ml–1 mouse laminin. All ECM proteins were obtained from
Collaborative Biomedical Products (Becton Dickinson, Bedford,
MA, USA). Dilutions were done in cold PBS. The plates were
covered and stored at 4°C until use. At least 1 h before the plates
were used, the ECM liquid was discarded, and the wells were
blocked with 125 ml of a solution of 1% bovine serum albumin,
(BSA; Sigma Chemical Co., St Louis, MO, USA) in PBS at 37°C.
Immediately prior to addition of the cells to the wells, the BSA
solution was poured off. The cells were harvested by trypsiniza-
tion 2, 24 and 72 h after photosensitization. They were suspended
in media containing 10% FCS for approximately 30 min to inacti-
vate the trypsin. During this time live cells were counted by
haemocytometer. The cells were centrifuged and resuspended in
RPMI containing 1% BSA at a density of 2–5 ´ 105 cells ml–1.
Then, 0.10 ml of this suspension was placed in each of the wells
previously prepared with ECM proteins, as well as counted in trip-
licate on a Beckman Model LS3801 scintillation counter to deter-
mine input radioactivity. Adhesion assay incubations were done
for 2 h at 37°C before non-adherent cells were washed off with
PBS. Each well was washed three times with 150 ml of PBS. The
wells were examined using a microscope to ensure that this
protocol removed the cells from the blank wells. A total of 150 ml
of a detergent solution (0.1 mol l–1 sodium phosphate, pH 7.5,
1 mol l–1 sodium chloride, 10% Triton X-100, 5% sodium deoxy-
cholate, 1% sodium dodecyl sulphate) were added to each well to
lyse the cells. Then, 125 ml from each well were counted for
radioactivity. In each case, the per cent adhesion was calculated as
the percentage of radioactivity that bound to the matrix protein
compared to the input counts. In all cases, these values were
normalized to the percentage adhesion occurring with the
untreated OVCAR 3 cell line. Adhesion values were typically
determined by quadruplicate measurements.
Antibody blocking
Because the b1 integrin subunit is widely used to bind to different
ECM components across a variety of cell types, use of b1 in
OVCAR 3 cells was determined by antibody blocking experi-
ments. One hundred microlitres of 2 mg ml–1 solutions of collagen
IV and fibronectin, and 10 mg ml–1 solution of laminin were placed
in Falcon ‘Probind’ 3915 plates for 24 h at 0°C before the wells
were blocked with 125 ml of 1% BSA in PBS for 1 h. At the same
time, OVCAR 3 cells were allowed to incubate with 8.5 mCi ml–1
[35S]methionine. Afterward, the cells were harvested by trysiniza-
tion after rinsing once with 10% FCS–RPMI and once with PBS
without calcium and magnesium. The cells were resuspended in
10% FCS–RPMI and incubated at 37°C for 30 min. The cells were948 JM Runnels et al
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then centrifuged, and resuspended in RPMI with 1% BSA at a
concentration of 5 ´ 105 ml–1. Then, 2 mg ml–1 of anti-b1 antibody
were added. Five minutes later 100 ml of cell suspension were
added to the appropriate protein-coated well as in the adhesion
assay. Following a similar protocol, blocking of binding to
fibronectin by an antibody to the a3 and a5 subunits was also
measured.
Antibody staining for focal adhesion plaque
visualization
Indirect immunofluorescence of the b1 integrin was accomplished
following the protocol of Carter et al (1990). Basically, coverslips
were washed with chloroform and methanol to reduce cellular
interactions with glass. The coverslips were placed in 35-mm
tissue culture dishes and coated with 250 ml of 20 mg ml–1 collagen
IV at 4°C overnight. Photosensitization was performed as
described above except that the fluence used was 1.0 J cm–2 in
order to obtain 50% survival. One hour after treatment the cells
were collected by trypsinization, washed with RPMI containing
1% BSA and 100 mg ml–1 soybean trypsin inhibitor (Sigma
Chemical Co., St Louis, MO, USA), and 250 ml of a 1.67 ´ 106
cells ml–1 dilution were placed in the coverslip dishes in RPMI
with 1% BSA. The cells were allowed to incubate for 2 h before
indirect immunofluorescence was done. The cells on collagen IV
were washed with PBS twice, and fixed with 1% formalin for no
more than 5 min. After washing with PBS with 1% filtered horse
serum, the cells were stained with a 2 mg ml–1, stock of anti-human
b1-integrin (Clone P4C10) (Telios Pharmaceuticals, Inc., San
Diego, CA, USA) for 1 h at room temperature. They were then
washed again, and incubated with fluorescein isothiocyanate
(FITC)-conjugated conjugated goat anti-mouse IgG (Sigma
Chemical Co., St Louis, MO, USA) for another hour at room
temperature. The plates were washed again with PBS and the fluo-
rescence was preserved by mounting the coverslips on slides using
Gel/Mount (Biomeda Corp., Foster City, CA, USA). Fluorescence
was imaged using an epi-illumination fluorescence microscope
(Zeiss, Oberkochen, Germany) equipped with a Pulnix Image
Intensifier, Sony video monitor, and an IBM personal computer
AT. FITC was excited using a 450–490 nm bandpass filter, and
emission was imaged using a 514 nm longpass filter.
Modulation of photosensitization effects
Photosensitization experiments were performed in the presence
of catalase (CAT), superoxide dismutase (SOD), sodium azide
(NaN3), and heavy water (D2O) in order to evaluate the effects of
radicals on cellular adhesion. Photosensitizations were done as
described above, except that irradiations were done in the presence
of 1500 U ml–1 CAT, 500 U ml–1 SOD, 5 mM NaN3, or 90% D2O.
Following irradiations, the cells were placed in media and incu-
bated at 37°C for 30 min before they were harvested for cellular
adhesion analysis.
Cellular localization of BPD-MA
Cell preparation
A total of 3 ´ 105 OVCAR 3 cells were plated on a microscope
cover slip and incubated for at least 24 h. BPD-MA was dissolved
in complete medium to a final concentration of 0.092 mmol l–1 and
incubated for 3 h. For 20 min, Rhodamine 123 (R123, Eastman
Kodak, Rochester, NY, USA) was added to a final concentration of
0.01 mmol l–1 for co-incubation (Chen, 1998). The coverslips were
rinsed in PBS and mounted with PBS on a microscope slide using
0.02-mm-thick distance holders in order to prevent compression of
the cells. The samples were imaged without delay.
Microscopy
A Leica confocal laser scanning microscope (Leica, Heidelberg,
Germany) consisting of a Leica TDS 4D scanner attached to a
Leitz DM IRD inverted microscope was operated using the TCS-
NT software package. Radiation (488 nm) from an Argon laser
was used for excitation. A 100 ´ oil immersion objective was used
to image a 100 ´ 100 mm area at 1024 ´ 1024 pixels resolution.
The instrument allowed simultaneous recording of three signals.
One channel was used for acquiring a transmission image
(differential interference contrast, DIC). The other two channels
collected fluorescence signals in either the green range (530 nm
bandpass filter), or the red range (590 nm longpass filter). The
green and red images were combined for the overlay image.
RESULTS
Adhesion to ECM proteins after mild photosensitization
To investigate the effects of BPD-MA photosensitization on
cellular adhesion properties of surviving tumour cells, OVCAR 3
cells were assayed after mild photosensitization. Photosensitization
which yielded approximately 85% survival decreased the adhesion
of OVCAR 3 cells to ECM proteins following irradiation (Figure
1). Two hours following irradiation, binding to laminin was
reduced to 39% of control, binding to fibronectin was reduced by
Table 1 Effect of modulators of photosensitization on cellular adhesion of OVCAR 3 cells to ECM proteinsa
ECM protein CAT SOD NaN3 D2O
Collagen IV 98.76 ± 7.93 95.99 ± 13.47 125.54 ± 10.13c 101.17 ± 7.40
Fibronectin 99.96 ± 9.88 97.75 ± 5.74 117.29 ± 10.82b 90.93 ± 15.64
Laminin 106.26 ± 17.62 90.60 ± 12.04 158.69 ± 25.37b 76.15 ± 7.41
Vitronectin 103.13 ± 3.56 93.89 ± 2.39 104.52 ± 10.40 90.12 ± 6.85c
aBPD-MA photosensitization was performed in the presence and absence of the compounds listed in the table. Thirty minutes
following irradiation, cells were harvested for adhesion assays. Each value represents the per cent adhesion obtained with the
compound compared to that obtained when cells were photosensitized in its absence. Mean values and standard deviations from
4–5 different experiments have shown. Every experiment was performed with quadruplicate wells for each protein (n = 16–20).
bSignificant at the 5% level; c significant at the 1% level using a paired t-test.Photosensitization damage to cellular adhesion 949
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47% of control, while binding to collagen IV and vitronectin were
least affected (59% and 64% of control respectively). By 24 h,
cellular adhesion had begun to recover, such that laminin binding
returned to 79% and vitronectin binding returned to 92% of the
untreated control OVCAR 3 cells. By 72 h, adhesion to all of the
ECM proteins returned to essentially 100% of control values. To
eliminate any contribution BPD-MA dark effects might make to the
data, adhesion of cells treated with BPD-MA in the absence of light
was measured. These data are also presented in Figure 1. In each
case, no significant effect of BPD-MA alone could be seen, indi-
cating that the effects on cellular adhesion are the result of photo-
sensitization and not binding of the photosensitizer to the integrin
receptors directly at their sites of ECM interaction.
Determination of integrin expression by OVCAR 3 cells
To determine which integrins the OVCAR 3 cells use to bind to
ECM proteins, the cellular adhesion assay was done in the pres-
ence of competing antibody. Because the b1 subunit is the most
commonly used b subunit, antibody against it was chosen as a
major competing antibody in the adhesion and the immunofluores-
cence studies. These data, presented in Figure 2, show that
OVCAR 3 cells rely heavily on integrins possessing the b1 subunit
to bind to collagen IV and laminin; surprisingly, the b1 antibody
inhibited fibronectin binding by only about 20%.
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Figure 1 Time course of photosensitization effects on cellular adhesion to
ECM proteins. OVCAR 3 cells were allowed to adhere to various ECM
proteins for 2 h at various times following BPD-MA photosensitization. The
data obtained on cells harvested 2 and 72 h post photosensitization are
compiled from four experiments, while the 24 h data are derived from five
experiments. Levels of significance using a paired t-test: *, significant at the
5% level; **, significant at the 1% level
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Figure 2 Cellular adhesion in the presence of competing b1 antibody.
OVCAR 3 cells were radioactively labelled with [35S]methionine and allowed
to adhere to collagen IV, fibronectin and laminin in the presence or absence
of an inhibitory anti-b1 antibody (P4C10). Values are expressed as the
percentages of radioactivity which adhered to the protein-coated wells
compared to the total amount added. Values are the results of two
experiments done in triplicate
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Figure 3 Cell surface expression of b1 integrins after photosensitization.
OVCAR 3 cells were grown on glass cover slips, and treated with BPD-MA
alone or with BPD-MA and light. The cells were fixed and reacted with mouse
monoclonal anti-b1 antibody (P4C10) and FITC-conjugated goat anti-mouse
IgG and examined by fluorescence microscopy as described. (A) Untreated
control cells; (B and C) treated with BPD-MA alone; (D and E) treated with
BPD-MA and light950 JM Runnels et al
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Effect of photosensitization on focal adhesion sites
Integrins form a link between the extracellular environment and
the internal cytoplasm. In order to function in signal transduction
from one environment to the other, integrins cluster to form focal
adhesion sites (Kornberg and Juliano, 1991; Schwartz, 1992).
Damage at these sites interferes with the ability of integrins to
interact effectively with the cell’s environment. To visualize
damage done by photosensitization with BPD-MA, OVCAR 3
cells were stained with a mouse monoclonal anti-human b1 inte-
grin antibody followed by a FITC-conjugated goat anti-mouse IgG
antibody, both before and 3 h following treatment (Figure 3). After
treatment, b1-containing integrins were present on the cell surface
in a diffuse pattern (Figure 3 D, E): they were less organized into
focal adhesion plaques (FAPs) than on untreated or cells treated
with BPD-MA alone (compare Figure 3 A, B, C with D and E)
These findings are consistent with a loss of integrin function
resulting from photosensitization damage which manifests itself as
an inability to bind to ECM proteins (Figure 1).
Effect of quenchers and D2O on photosensitized
damage to cellular adhesion
Photosensitization damage in biological systems is mediated by
active molecular species, including reactive oxygen radicals.
Singlet oxygen is considered to make a major contribution via a
type II mechanism for a number of photosensitizers (Halliwell,
1989; Henderson and Dougherty, 1992). We have previously
reported detailed analyses of the photophysical and photosensi-
tizing properties of BPD-MA (Aveline et al, 1994, 1995) and have
established the singlet oxygen yield in organic solvents to be about
0.78. One of our studies (Aveline et al, 1995) confirmed that the
essentials of photophysics of this molecule remained the same
upon complexation with human serum albumin. Taken together,
these data would confirm an important role for singlet oxygen in
the photosensitization process. However, other oxygen species,
such as superoxide and hydrogen peroxide, may contribute as well
(Maillard et al, 1980, Ben Hur et al, 1985; Athar et al, 1989; Kimel
et al, 1989). To establish how important any of these species might
be in photosensitization damage to the integrins, cellular adhesion
was measured after photosensitization in the presence of various
compounds which can modulate the effects of reactive oxygen
species. These data are presented in Table 1.
The presence of neither catalase nor superoxide dismutase at
the time of irradiation altered adhesion to ECM proteins when
measured 30 min following irradiation. These data suggest that
hydrogen peroxide and superoxide do not contribute substantially
to the damage at the cell surface. Azide did partially reverse the
effects of photosensitization on cell adhesion, implicating singlet
oxygen and/or radicals as the damaging species. This reversal was
significant for binding to collagen IV, fibronectin and laminin.
Further studies using deuterium oxide to lengthen the lifespan
of singlet oxygen potentiated effects on cellular adhesion to
fibronectin, laminin and vitronectin; the effect was statistically
significant only in the case of binding to vitronectin.
Localization of BPD-MA
Co-localization using R123 demonstrated that, although BPD-MA
fluorescence was very clearly localized to mitochondria, it obvi-
ously transgressed those areas co-stained by R123 (Figure 4A) and
had a generally cytoplasmic pattern (Figure 4 B, C). This extra-
mitochondrial staining had a diffuse and a patchy distribution
(Figure 4B). Despite the non-plasma membrane localization of the
photosensitizer, the adhesion and immunofluoresence data
presented above indicate that at least some of the damage done
with BPD-MA photosensitization is manifested at the cell surface.
Since the extent of the damage was not affected by most of the
modulators described in Table 1, it is possible that damage occurs
at cellular sites which affect integrin function, but are sequestered
at sites inaccessible to the modulators.
Prior to performing co-localization studies, we established that
there was no cross-talk of the fluorescent dyes at the concentra-
tions used (0.01 mmol l–1, R123; 0.092 mmol l–1, BPD-MA). This
tenfold difference in concentrations reflects the more than tenfold
lower fluorescence quantum yield of BPD-MA (jF = 0.06)
(Aveline et al, 1994) as compared to R123 (j = 0.99).
In vivo adhesion characteristics of OVCAR 3 cells
before and after photosensitization
As in the in vitro situation, exposure of OVCAR 3 cells to BPD-
MA in vivo did not significantly affect the adhesion of the cells to
the ECM proteins when compared to control ascitic cells (Figure
5). Treatment with BPD-MA and light reduced adhesion to
collagen IV to 20%; fibronectin to 14%; laminin to 15%; and
vitronectin to 20% of that seen with ascites control cells. More
dramatic, however, was the difference in adhesion between
OVCAR 3 cells in vitro and in vivo. OVCAR 3 ascites adhered to
collagen IV, fibronectin, laminin and vitronectin at 20%, 7%, 11%
and 18% of the respective in vitro OVCAR 3 values.
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Figure 4 Cellular localization of BPD-MA. Confocal fluorescence imaging of
OVCAR 3 cells incubated for 3 h in 0.092 mmol l–1 BPD-MA and 20 min co-
incubated in 0.01 mmol l–1 R123. (A) Green fluorescence of R123-stained
mitochondria; (B) red fluorescence of BPD-MA; (C) combination of (A) and
(B) images, where yellow indicates co-localization of red and green
fluorescence; (D) DIC transmission imagePhotosensitization damage to cellular adhesion 951
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DISCUSSION
The role of integrin-mediated functions, such as cellular adhesion
to ECM or endothelial cells, plays an important role in many
biologic processes including cell growth, differentiation, malig-
nant transformation and metastasis. The present study is an initial
investigation to determine if alterations relevant to any of these
processes occur as a consequence of BPD-MA-based PDT. The
findings suggest that, indeed, transient changes in integrin func-
tion and cellular adhesion do occur when OVCAR 3 cells are
subject to PDT with BPD-MA.
The data presented here demonstrate that photosensitization
damage to OVCAR 3 cells causes a decreased ability of the cells to
bind to all four of the ECM components tested. The loss of adhe-
sion was accompanied by the loss of FAPs and the appearance of a
diffuse pattern of b1 fluorescence after photosensitization (Figure
3). Even though FAPs disappeared, the cells retained their capacity
to adhere to a collagen IV matrix (Figures 1 and 3) suggesting that
either alternative b subunit integrins, or other adhesion molecules,
were utilized for this binding. Consistent with this, the baseline
binding of OVCAR 3 cells to fibronectin was inhibited by a5 and
b1 integrins (Figures 2 and 6). The implications of these data
clearly need to be studied further. However, there is ample infor-
mation in the literature to project on what some of these implica-
tions might be.
Numerous changes in integrin expression have been noted
between normal cells and their oncogenic counterparts, although
the overall picture is not straightforward, and changes in integrin
expression appear to be a function of cell/tissue type. Plantefaber
and Hynes (1989) reported a significant loss in expression of a5b1
integrin (fibronectin) in transformed rodent fibroblasts (Plantefaber
and Hynes, 1989). Likewise, Chinese hamster ovary cells (CHO)
that have been transfected with human a5 and b1 cDNAs regained
their ability to synthesize a5b1 integrin, and concomitantly lost their
tumorigenicity in nude mice (Giancotti and Ruohslati, 1990). In
addition, a5b1 expression correlated with a decreased ability to
migrate in vitro, a property indicative of metastatic potential in
vivo. On the other hand, CHO cells with decreased fibronectin inte-
grin receptor expression compared to the parent cell line migrated
less toward fibronectin in vitro and formed faster growing tumours
in vivo than the parent cells (Schreiner et al, 1989). Very few data
exist on the effects of PDT on cell adhesiveness. BPD-MA PDT of
fibroblast interfered with cell adhesion without altering integrin
expression (Margaron et al, 1997), which is consistent with obser-
vations in our study. HPD PDT caused a reduced adhesion of
colonic cancer cells to endothelial cells (Vonarx et al, 1995). Other
membrane and non-membrane agents also modulate the expression
of integrins (Danilov and Juliano, 1989; Conforti et al, 1990; Elices
et al, 1991).
As demonstrated by comparing Figures 1 and 5, ascitic cells
derived from the OVCAR 3 cell line adhere to ECM proteins far
less than OVCAR 3 cells in vitro. However, once maintained in
culture for a few days, ascites cells return to an in vitro adhesion
pattern (data not shown). This difference probably reflects an in
vivo signal which is absent in vitro, due to a change of phenotype
which has been reported (Mareel et al, 1991). Alternatively, the
decreased adhesion seen in vivo may result from ligand occupa-
tion of the binding sites (Wilhelm et al, 1988) and OVCAR 3
ascites are found to contain glandular structures ex vivo which are
not seen when OVCAR 3 cells are maintained in vitro similar to
the situation with mouse mammary cells (Aggeler et al, 1991). It
appears that initiation of ovarian malignancy requires free integrin
ligand sites: joint administration of ovarian tumour cells and RGD
peptides prevents peritoneal seeding in experimental animals
(Yamamoto et al, 1991). In the experiments presented here, the
reduced capacity of the ex-vivo ascites cells to bind ECM proteins
in an in vitro adhesion assay when compared to in vitro-cultured
OVCAR 3 cells did not prevent tumour spread.
Occupation of the tumour cell integrin binding sites in this estab-
lished malignant state may, in fact, have contributed to tumour
spread, as occupation of the fibronectin integrin ligand site has been
demonstrated to induce collagenase and stromelysin expression in
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Figure 5 Cellular adhesion to ECM proteins after in vivo photosensitization.
OVCAR 3 cells were injected intraperitoneally into nude mice, and ascitic
tumours allowed to develop for 14 days. The mice were then exposed to
BPD-MA PDT, as described. One hour later, the ascites were harvested and
the OVCAR 3 cells were radioactively labelled overnight. The following day
the cells were used in adhesion assays as described above. All data are
derived from triplicate samples from at least two experiments. *, significant at
the 5% level using a paired t-test
Figure 6 Cellular adhesion in the presence of competing a3, a5 and b1
antibodies. OVCAR 3 cells were radioactively labelled with [35S]methionine
and allowed to adhere to fibronectin in the presence or absence of an
inhibitory anti-a3, a5 or b1 antibody. Values are expressed as the percentages
of radioactivity adhering to the protein-coated wells compared to the total
amount added. Values are the results of two experiments done in triplicate
b1another system (Werb et al, 1989). In this model, a temporary loss in
adhesive abilities after PDT in vivo would have far different effects
than occupation of the ligand binding site, since the former results
from a disruption of functional integrin sites and concomitent loss of
the signalling mechanism, while the latter is transmitting a signal.
As in the in vitro situation, however, BPD-MA PDT resulted in an
overall decrease in ascitic cell binding to ECM proteins when
compared to untreated controls. What the long-term consequences
of this might be, can only be speculated upon. However, other
studies in an ovarian cancer model and high-dose BPD-MA-based
PDT (Molpus et al, 1996) did not show any increase in tumori-
genicity in treated mice. The effect of low-dose PDT in this in vivo
model, which would provide a better comparison with the present
study, was not evaluated.
Our data (Table 1) indicate that damage done to the cellular
adhesion apparatus does not occur through formation of superoxide
(O2
–) or H2O2 (hydrogen peroxide) species during photosensitiza-
tion at the sites of the integrins, since the presence of neither SOD
nor catalase affected the degree of binding to ECM proteins. While
exogenous H2O2 impairs integrin function (Zhang et al, 1994), this
species does not appear to damage the cell surface under BPD-MA
PDT conditions. We cannot rule out that O2
– or H2O2 damage may
occur internally at sites inaccessible to SOD and catalase.
Furthermore, damage could be the result of conversion of O2
– or
H2O2 to highly reactive oxidants such as hydroxyl radicals, •OH
(Halliwell, 1989). Data obtained in the presence of NaN3 suggest
the importance of singlet oxygen. These observations are consistent
with our previous studies on the photophysical characterization of
BPD-MA where a quantum yield of 0.78 was reported for singlet
oxygen. The minimal enhancement in D2O points to the complexity
of biological action of active molecular species.
In summary, this study shows that photosensitization with BPD-
MA transiently reduces the binding of ovarian cancer cells to the
four ECM components tested both in vitro and in vivo.
Interestingly, after photosensitization, the b1-containing integrins
on the cell surface could still react with anti-b1 antibody
suggesting that the subunit was still structurally intact, although
FAPs (a functional attribute) became diffuse (Figure 3). Co-local-
ization showed that BPD-MA localizes in or around the mitochon-
dria with no marked fluorescence of the cell membrane. Taken
together, these data indicate that the loss in integrin function arises
largely through intracellular damage rather than through direct
damage to the integrin proteins on the cell surface. These data also
imply that, if cellular adhesion to ECM and formation of FAPS are
important determinants of metastasis as has been suggested
(Giancotti and Ruoshlahti, 1990), then PDT clearly has the poten-
tial to modulate metastasis and this aspect of photodynamic sensi-
tization needs further evaluation.
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